AKTIS ONCOLOGY INC
AKTSNASDAQ🏆 #2130 by market capUS Equity
$24.77▲ $0.00 (+0.02%)
Live1h▲ 0.7%
24h▲ 0.0%
7d▲ 9.4%
14d▲ 11.0%
30d▼ 3.1%
1y—
🏦Market Cap
$1.32B
Small Cap
📈Revenue Growth (YoY)
+49.9%
High Growth
📊Gross Margin
-11.6%
Thin
💵FCF Margin
—
⚖️P/S Ratio
137.0x
Expensive
Otter Score
53
Weak
Earnings
Q2 · 2026Reported 2026-05-11Earnings Per Share
Actual
-0.38
Expected
-0.31
miss
−22.60%
Revenue
Actual
$3.23M
Expected
$1.93M
beat
+67.20%
Consensus estimates
Recent quarters
Q2 2026
-0.38
miss
Q1 2026
-18.19
beat
Q4 2025
-1.39
miss
Q4 2024
-0.04
beat